Iovance Biotherapeutics, Inc.
$3.69B- Market cap
- $3.98B
- Debt
- +$1.00M
- Cash
- −$296.98M
Capital structure 100% equity / 0% debt · EV / Revenue 13.99x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
IOVA · current priceP/S 15.11x
$8.79Latest market snapshot
Implied fair value · at ZNTL's multiple
$2.4771.9% below market
0.58 IOVA revenue / share×4.24x ZNTL P/S=$2.47
Market $8.79Implied $2.47
ZNTL · current priceP/S 4.24x
$3.99Latest market snapshot
Implied fair value · at IOVA's multiple
$14.22256.3% above market
0.94 ZNTL revenue / share×15.11x IOVA P/S=$14.22
Market $3.99Implied $14.22